Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
VSF-173 in induced excessive sleepiness
NCT00467441Phase 2Completed
- Sponsor
- Vanda Pharmaceuticals Inc.
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of VSF-173 in Excessive Daytime Sleepiness (EDS), sponsored by Vanda Pharmaceuticals Inc.. Status: completed.
02
Drugs
VSF-173
03
Conditions
Excessive Daytime Sleepiness (EDS)
Beyond the preview
Go deeper on NCT00467441.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00467441.